Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature Medicine 10, 1169 - 1171 (2004)
doi:10.1038/nm1104-1169
Transporter of a malaria catastrophe
Thomas E Wellems1
- Thomas E Wellems is in the Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892-8132, USA. e-mail: tew@helix.nih.gov
Abstract
Amantadine, a proton-channel blocker used to treat influenza, also inhibits growth of the malaria parasite Plasmodium falciparum. The drug is most active against parasite strains resistant to the increasingly ineffective drug chloroquine. The molecular basis of this enhanced activity is now examined, opening the door to new ways to attack chloroquine resistance.
The introduction of chloroquine for treatment of malaria after World War II had a tremendous impact on global public health. In Africa, its widespread use in children nearly halved deaths from P. falciparum
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Chloroquine resistance?discovering the missing link?Nature Medicine News and Views (01 Jan 1998)
How chloroquine worksNature News and Views (09 Jan 1992)
See all 7 matches for News And ViewsRESEARCH
A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistanceThe EMBO Journal Article (06 Jul 2005)
Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparumThe EMBO Journal Article (12 Jul 2006)
See all 19 matches for Research